Latest News
Anxiety Sensitivity Associated With Migraine Severity in Women
Odds of Autism Up in Children With Congenital Heart Disease
Early Behavioral Inhibition Predicts Greater Anxiety in Adolescence With High Stress Levels
$8 Billion Award Granted in Risperdal Lawsuit
A Daytime Nap May Contribute to Altered Emotional Processing in Depression
Food for Thought: Mood Improvements Following Dietary Modification
Diet Intervention Can Cut Depression Symptoms in Young Adults
Gender-Affirming Surgery May Aid Long-Term Mental Health
Suicidality, Depression, and Anxiety Linked to Tension Headaches
New Study Resuscitates Potential of Deep Brain Stimulation in Treatment-Resistant Depression
Depression, Bipolar Disorder Linked to Impaired Adult Visuospatial Memory
Diagnosis of Intellectual Disability, Depression More Likely For Students Younger Than Their Peers
Burnout Linked to Poor Quality Care
Treatment-Resistant Schizophrenia in Urban Environments
High-Risk Social Challenge May Effectively Detect Social Deficits in Adults
Antibody Titers to Cytomegalovirus, Toxoplasma Linked to Bipolar Disorder
Mother-Infant Psychotherapy May Prevent, Reduce Postpartum Depression
Commemorating Mental Illness Awareness Week
Despite No Change in Depression Prevalence, Proportion of Seniors Taking Antidepressants More Than Doubles
Latest Features
Schizophrenia, Bipolar Disorder, and the Psychosis Continuum
Awareness of differences between psychosis in schizophrenia and bipolar disorder and varying presentations in patients can assist providers with diagnosis and treatment.
Understanding CBD: How to Advise Patients About Existing Laws, Clinical Evidence, and More
At Psych Congress 2018, Andrew Penn from the UCSF School of Nursing provides insight into the use of CBD in clinical practice.
Drug-Free Chronotherapies Represent Unique Treatments for Depression
Researchers found that bright light therapy is a suitable option for those who must avoid antidepressant medications, such as individuals who are in perinatal and geriatric populations.
Insulin Resistance in Schizophrenia Occurs With and Without Antipsychotics
Researchers found data that showed patients with schizophrenia have an increased risk for metabolic disorders, and aripiprazole, lurasidone, and ziprasidone may offer the lowest risk for weight gain.
Is There a Link Between Drugs for Parkinson Disease and Gambling Disorders?
Pathological gambling was recently identified as a complication of Parkinson disease and its pharmacological treatment, especially high-dose dopaminergic agonists.
